Skip to content

Published Studies

Article Type
Health Area
Health Condition / Disease
Cancer

Nicotinamide Riboside Restores T-Cell Function in Tumors by Improving Mitochondrial Health: Preclinical Findings

Synopsis T cells that infiltrate tumors often become exhausted and lose their ability to fight cancer due to poor mitochondrial function and reduced mitophagy. This exhaustion involves lasting cha...

Read more
Cancer

The Effects of Nutraceutical and Drug Cocktails in Duchenne Muscular Dystrophy: Preclinical Findings

Synopsis Duchenne muscular dystrophy (DMD) causes muscle weakness leading to respiratory failure. Earlier, quercetin showed temporary respiratory benefits in a mouse model. This study tested querc...

Read more
Cancer

Nicotinamide Riboside Decreased DNA Damage in Liver Cells: Preclinical Findings

Synopsis Hepatocellular carcinoma (HCC) is a fast-growing liver cancer, but its exact origin has been unclear. Using human data and mouse models, researchers found that HCC starts mainly from live...

Read more
Cancer

Nicotinamide Riboside Reduces Liver Inflammation and DNA Damage: Preclinical Findings

Synopsis Obesity increases the risk of liver cancer (hepatocellular carcinoma, HCC), but the exact mechanisms were unclear. This study found that a liver protein called URI links excess nutrients ...

Read more
Cancer

Inhibition of NAMPT and CD73 Suppresses Tumor Growth: Preclinical Findings

Synopsis Researchers are exploring new ways to treat ovarian cancer by targeting how tumor cells produce and recycle energy. This study focused on NAD+, a key molecule for cellular metabolism, and...

Read more
Cancer

Increasing NAD+ with Nicotinamide Riboside Prevents Liver Cancer Driven by URI: Preclinical Findings

Synopsis The molecular causes of liver cancer (hepatocellular carcinoma, HCC) are not fully understood. This study used genetically modified mice to show that when liver cells produce too much of ...

Read more
Cancer

NR and NMN Influence NAD+ Metabolism to Improve Anti-Cancer Therapy: Preclinical Findings

Synopsis In human cells, NAD+ is mainly produced through “salvage” pathways that recycle precursors like nicotinamide, nicotinic acid, and nicotinamide riboside (NR). Blocking this process with th...

Read more